Placebo to ARGX-119 concentrate for solution for infusion, ARGX-119
ARGX-119-2303
Phase 2 small_molecule active
Quick answer
Placebo to ARGX-119 concentrate for solution for infusion, ARGX-119 for Amyotrophic Lateral Sclerosis (ALS) is a Phase 2 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Amyotrophic Lateral Sclerosis (ALS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active